Carbonic Anhydrase Inhibitor2 (compound 7c) 是一种针对 Carbonic Anhydrase II 抑制剂，有效降低青光眼兔眼压。

Methazolamide-D6 is intended for use as an internal standard for the quantification of methazolamide by GC- or LC-MS. Methazolamide (T0106) is a carbonic anhydrase inhibitor. It reduces intraocular pressure and cerebrospinal fluid flow in a rat model of glaucoma. Methazolamide (T0106)reduces electroshock-induced seizures in rats with an ED50 value of 19.2 mg/kg. It also inhibits production of reactive oxygen species (ROS)in a primary cortical neuron (PCN)cellular model of subarachnoid hemorrhage (SAH)and reduces cerebral edema in a mouse model of SAH.3 Methazolamide (T0106) is larvicidal,with a 50% larvicidal concentration (LC50)value of 724 ppm,but has no activity when administered in the diet to adult A. aegypti. Formulations containing methazolamide have been used in the treatment of glaucoma.

M 12325 is used in the production of furosemide; rhinitis and occupational asthma were observed in workers from a lasamide production line.

Alpha-Pyrone对Tyrosinase，Carbonic anhydrase 1和Carbonic anhydrase 9具有抑制活性，广泛应用于生物化学实验和药物合成研究。

hCAI/II/IV-IN-28(WAY-638358) 是一种有效的碳酸酐酶抑制剂，具有潜在抗惊厥活性。

Carbonic anhydrase inhibitor 6 是一种高效的人碳酸酐酶 (hCA) 抑制剂，抑制 hCA IX，hCA II，hCA XII和hCA I，可用于研究碳酸酐酶异常引起的疾病。